As mentioned, the plasma levels of urotensin II are markedly increased in several clinical conditions, including chronic kidney disease, haemodialysis6, and diabetes mellitus7, where plasma renin and aldosterone can be inappropriately high for the volume status of the patients. Here, REN is linked to diabetes mellitus.